Results 101 to 110 of about 5,253,073 (166)
Aim: Fruquintinib (Fruq), a selective VEGFR 1/2/3 inhibitor, showed a significant progression-free survival (PFS) benefit in the Phase III FRUTIGA trial for advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma.
Nan An +13 more
doaj +1 more source
Background A thorough examination of psychosocial problems and individual patient experiences could contribute to a better understanding of the needs of advanced stage lung cancer patients and the development of personalized care models.
Dilek Yıldırım, Vildan Kocatepe
doaj +1 more source
Mesothelioma is a rare cancer of the thin lining that mainly covers the lungs and abdominal cavity. An average of 24 cases of mesothelioma was diagnosed per year in Ireland between 1994 and 2010 (Table 1), representing less than 0.2% of all invasive ...
National Cancer Registry Ireland (NCRI)
core
Laryngeal preservation versus upfront laryngectomy in advanced laryngeal cancer
Chrisanda Si Ying Lee +6 more
doaj +1 more source
Cancer Trends: non-Hodgkin’s lymphoma (NHL)
An average of 660 cases of non Hodgkin’s lymphoma (NHL) was diagnosed per year in Ireland between 2007 and 2011 (Table 1). Incidence rates were slightly higher in males than in females where NHL was the 5th and 8th most common cancer diagnosed ...
National Cancer Registry Ireland (NCRI)
core
Advances in Colorectal Cancer [PDF]
Nikolaos I. Nikiteas +3 more
openaire +4 more sources
Cancer Trends: Hodgkin’s lymphoma
An average of 101 cases of Hodgkin’s lymphoma (HL) was diagnosed per year in Ireland between 1994 and 2011, equating to an incidence rate of 2.5 cases per 100,000 per year (Table 1).
National Cancer Registry Ireland (NCRI)
core
Advancing on pancreatic cancer [PDF]
openaire +2 more sources
[[abstract]]Purpose: Dyspnea is a multidimensional phenomenon among advanced cancer patients. We aim to explore the association between bio-psychosocial-spiritual problems and dyspnea among advanced cancer patients in Taiwan.
Chih-Te Ho;Hua-Shui Hsu;Chia-Ing Li;Chiu-Shong Liu;Chin-Yu Lin;Cheng-Chieh Lin;Wen-Yuan Lin
core

